| Q34174307 | Advances in iron chelation: an update |
| Q37751655 | Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. |
| Q35085094 | Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells |
| Q37100186 | Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore |
| Q35131902 | Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury. |
| Q36777049 | Aldose reductase, oxidative stress and diabetic cardiovascular complications |
| Q35947855 | Aldose reductase, oxidative stress, and diabetic mellitus |
| Q34149709 | Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress |
| Q45777435 | Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts. |
| Q92662725 | Glucose Metabolism in Cardiac Hypertrophy and Heart Failure |
| Q34034801 | Hepcidin is involved in iron regulation in the ischemic brain |
| Q26773988 | Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity |
| Q37780103 | Hypoxia inducible factor 1 (HIF-1) and cardioprotection |
| Q38229803 | Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia. |
| Q38109649 | Impairment of calcium ATPases by high glucose and potential pharmacological protection. |
| Q37312849 | Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke |
| Q52144821 | Ischemic stroke, inflammation, iron overload - Connection to a hepcidin. |
| Q57821349 | Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities |
| Q35130806 | Novel role for aldose reductase in mediating acute inflammatory responses in the lung |
| Q38046547 | Oxidative stress and myocardial injury in the diabetic heart |
| Q41588671 | Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes. |
| Q33849720 | Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress |
| Q89012656 | Pathological Roles of Iron in Cardiovascular Disease |
| Q33746091 | Polyol pathway exacerbated ischemia/reperfusion-induced injury in steatotic liver |
| Q34595686 | Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins |
| Q36405689 | Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury |
| Q84409655 | Protective effects of deferoxamine mesylate preconditioning on pancreatic tissue in orthotopic liver autotransplantation in rats |
| Q88970936 | Redox imbalance stress in diabetes mellitus: Role of the polyol pathway |
| Q36636071 | Reduction in mitochondrial iron alleviates cardiac damage during injury |
| Q42868863 | Salvianolic acid A displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury |
| Q36664001 | Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study |
| Q26744642 | The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited |